Case Report: Bispecific CD20/CD30-targeted chimeric antigen receptor T-cell therapy for non-Hodgkin’s lymphoma

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-05-08
DOI
https://doi.org/10.3389/fimmu.2025.1567149
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Bispecific CD20/CD30-targeted chimeric antigen receptor T-cell therapy for non-Hodgkin’s lymphoma

Hosein Kouros‐Mehr, Huaying Ruan, Jinhua Lu, Yuejiao Huang et al.
2 links
Frontiers in Immunology
CAR-T cell therapy research
article

Case Report: Bispecific CD20/CD30-targeted chimeric antigen receptor T-cell therapy for non-Hodgkin’s lymphoma

Hosein Kouros‐Mehr, Huaying Ruan, Jinhua Lu, Yuejiao Huang, Zhihong Liu, Xiang Liu, Han Wang, Yiming Gong
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
College of San Mateo (US), Nantong University (CN), Affiliated Hospital of Nantong University (CN), Shanghai First People's Hospital (CN), Regend Therapeutics (China) (CN)
Nantong University, Nantong Municipal Commission of Health and Family Planning
Openalex Percentile: Top 85%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.